Journal of Cystic Fibrosis 2023

4 papers
The 2023 edition of the Journal of Cystic Fibrosis highlights research centered on clinical management, genetic predictors of disease, and molecular structural analysis. A prominent theme involved the management of Pseudomonas aeruginosa infections, with studies investigating the correlation between adherence to care guidelines and incident infections, as well as global patterns in inhaled antibiotic prescriptions. Additionally, research utilized aggregated genetic modifiers to predict lung dysfunction in children aged five to six years, emphasizing early-life disease progression. In the realm of basic science, the journal featured work using cryogenic electron microscopy to examine the folding and conformational dynamics of the human CFTR protein. This research identified a novel potentiator binding site within the nucleotide-binding domains, providing data on alternative channel-gating mechanisms. Notable contributors during this year included Marianne S. Muhlebach, John J. LiPuma, and Lisa Saiman. Together, these studies represent an effort to link molecular-level discoveries with clinical practice and patient outcomes.

Top Authors

AuthorPapers
Oliver Biggs Clarke1
Qiongshi Lu1

Papers

Title
335 Cryogenic electron microscopy studies of human CFTR folding and conformational dynamics elucidate a novel potentiator binding site in the nucleotide binding domains that supports an alternative ch
Association of Pseudomonas aeruginosa incident infections with adherence to cystic fibrosis foundation care guidelines
WS09.05 Aggregated genetic modifiers predict lung dysfunction at age 5–6 years in children with cystic fibrosis
WS10.04 Analyzes of worldwide inhaled antibiotic prescriptions for Pseudomonas aeruginosa